The preliminary therapeutic evidence, plus the likely pharmacological benefits of 5?MeO?DMT as opposed to other classical psychedelics, has tested intriguing to scientists and pharmaceutical organizations alike, fueling a rising range of scientific trials which are presently in a variety of stages of advancement (Table 1). At this time, two medica